Latest News
InSysBio agrees new collaborative project with BeOne Medicines
29 January 2026 - Quantitative Systems Pharmacology (QSP) modelling specialist InSysBio announced on Wednesday an extension of its collaboration with oncology company BeOne Medicines.In this project, mechanistic translational modelling will be applie...
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
29 January 2026 - WuXi Biologics (HK:2269), a China-based global Contract Research, Development, and Manufacturing Organisation (CRDMO), announced on Wednesday that it has formed a collaboration with biomedical innovation company Sinorda Biomedicine ...
Solvonis expands SVN-015 into depression following positive preclinical data
28 January 2026 - London-based biopharmaceutical company Solvonis Therapeutics plc (LSE: SVNS) on Wednesday announced the expansion of its investigational compound SVN-015 into the treatment of depression, supported by preclinical data showing antide...
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
28 January 2026 - Biotechnology company Biogen Inc (Nasdaq:BIIB) announced on Wednesday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for litifilimab (BIIB059) to treat cutaneous lupus erythematosus (CLE)...
Glaukos receives FDA approval for repeat administration of iDose TR
28 January 2026 - Ophthalmic pharmaceuticals and medical technology company Glaukos Corporation (NYSE:GKOS) announced on Wednesday that the US Food and Drug Administration (FDA) has approved a new drug application (NDA) labeling supplement allowing r...